These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38504198)

  • 1. Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada.
    Dubois C; Fernandes H; Lin M; Martins KJB; Dyck JRB; Klarenbach SW; Richer L; Jess E; Hanlon JG; Hyshka E; Eurich DT
    BMC Public Health; 2024 Mar; 24(1):859. PubMed ID: 38504198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada.
    Lee C; Lin M; Martins KJB; Dyck JRB; Klarenbach S; Richer L; Jess E; Hanlon JG; Hyshka E; Eurich DT
    BMC Public Health; 2021 May; 21(1):843. PubMed ID: 33933061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada.
    Lee C; Round JM; Klarenbach S; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    Harm Reduct J; 2021 Jun; 18(1):61. PubMed ID: 34103058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014-2017 in Ontario, Canada.
    Lee C; Voaklander D; Minhas-Sandhu JK; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    Inj Epidemiol; 2021 Apr; 8(1):33. PubMed ID: 33906699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Cannabis Authorization in Patients With Cancer in the Prelegalization Era: A Population-Based Study.
    Karim S; Cheung WY; Bu J; Jess E; Kerba M
    J Pain Symptom Manage; 2020 Jun; 59(6):1223-1231. PubMed ID: 31887404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada.
    Lee C; Round JM; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    Can J Psychiatry; 2022 Jun; 67(6):470-480. PubMed ID: 34520280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis.
    Round JM; Lee C; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    BMC Public Health; 2020 Jun; 20(1):987. PubMed ID: 32576158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical Cannabis: Effects on Opioid and Benzodiazepine Requirements for Pain Control.
    O'Connell M; Sandgren M; Frantzen L; Bower E; Erickson B
    Ann Pharmacother; 2019 Nov; 53(11):1081-1086. PubMed ID: 31129977
    [No Abstract]   [Full Text] [Related]  

  • 9. Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada.
    Eurich D; Lee C; Zongo A; Minhas-Sandhu JK; Hanlon JG; Hyshka E; Dyck J
    J Epidemiol Community Health; 2020 Mar; 74(3):299-304. PubMed ID: 31831619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Predictors of Cannabis-Related Poisoning and Mental and Behavioral Disorders among Patients with Medical Cannabis Authorization: A Cohort Study.
    Zongo A; Lee C; Dyck JRB; El-Mourad J; Hyshka E; Hanlon JG; Eurich DT
    Subst Use Misuse; 2022; 57(10):1633-1641. PubMed ID: 35866679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of Benzodiazepine Use in Patients Prescribed Medical Cannabis.
    Purcell C; Davis A; Moolman N; Taylor SM
    Cannabis Cannabinoid Res; 2019; 4(3):214-218. PubMed ID: 31559336
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study.
    Zongo A; Lee C; Dyck JRB; El-Mourad J; Hyshka E; Hanlon JG; Eurich DT
    BMC Cardiovasc Disord; 2021 Sep; 21(1):426. PubMed ID: 34507536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of depressive disorders associated with medical cannabis authorization: A propensity score matched cohort study.
    Yana JL; Lee C; Eurich DT; Dyck JRB; Hanlon JG; Zongo A
    Psychiatry Res; 2023 Feb; 320():115047. PubMed ID: 36638694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Medical Cannabis Use After Recreational Cannabis Legalization in Canada.
    Nguyen HV; Grootendorst P; Mital S; Bishop L; McGinty EE
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):335-342. PubMed ID: 36720084
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study.
    Dubois C; Lunghi C; Eurich DT; Dyck JRB; Hyshka E; Hanlon JG; Zongo A
    Schizophr Res; 2024 Feb; 264():534-542. PubMed ID: 38330686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interrupted time series evaluation of the effect of cannabis legalization on intentional self-harm in two Canadian provinces: Ontario and Alberta.
    Cusimano MD; Carpino M; Walker M; Saarela O; Mann R
    Health Promot Chronic Dis Prev Can; 2023 Sep; 43(9):403-408. PubMed ID: 37707352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers in accessing medical cannabis for children with drug-resistant epilepsy in Canada: A qualitative study.
    Elliott J; DeJean D; Potter BK; Coyle D; Clifford T; McCoy B; Wells GA
    Epilepsy Behav; 2020 Oct; 111():107120. PubMed ID: 32570201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Canada: a population-based study.
    Sharma V; Weir D; Samanani S; Simpson SH; Gilani F; Jess E; Eurich DT
    BMJ Open; 2019 Sep; 9(9):e030858. PubMed ID: 31494618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec.
    Kalaba M; MacNair L; Peters EN; Eglit GML; Rapin L; Hage CE; Prosk E; Ware MA
    Cannabis Cannabinoid Res; 2021 Dec; 6(6):564-572. PubMed ID: 33998902
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in medical cannabis use in Ontario, Canada (2014 to 2019): Trajectory of trends, medical authorization patterns and association with recreational cannabis legalization.
    Imtiaz S; Nigatu YT; Ali F; Elton-Marshall T; Rehm J; Rueda S; Hamilton HA
    Prev Med Rep; 2024 Aug; 44():102805. PubMed ID: 39035360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.